Scholarlink

Purpose <p>To evaluate the pathologic outcomes of 90Y-TARE of HCC with resin microspheres prescribed using the single-compartment model and to correlate posttreatment dose with outcomes.</p> Methods <p>This retrospective single-center study included adult patients with HCC who underwent 90Y-TARE with resin microspheres before liver transplantation or surgery. Histopathologic evaluation of liver tissue was performed. Complete pathologic necrosis (CPN) was defined as 100% tumor necrosis, extensive necrosis as 50–99%, and partial necrosis as &lt; 50%. Posttreatment voxel-based dosimetry was conducted. Additional subgroup analysis was done to compare tumors with complete and incomplete necrosis.</p> Results <p>Among 28 patients (median age, 64 years [IQR, 57–69 years]); 86% males,75% BCLC 0-A) with 37 HCC tumors, complete, extensive and partial pathologic necrosis were achieved in 27/37(73%), 8/37(22%) and 2/37(5%) tumors, respectively. Tumors with CPN were significantly smaller than those without CPN (2.2 vs. 3.4&#xa0;cm, <i>P</i> = 0.03), with longer interval between the 90Y-TARE and liver surgery (274 vs. 143 days, <i>P</i> = 0.048). All tumors with a mean tumor absorbed dose ≥ 433&#xa0;Gy had CPN. Conversely, all tumors in which 4% or more of the tumor volume received a dose less than 100&#xa0;Gy had incomplete necrosis. ROC analysis identified D95 ≥ 133&#xa0;Gy (AUC 0.96 [95%CI: 0.9-1]) and V0-100 (%) &lt; 5% (AUC 0.9 [95%CI: 0.75–0.97]) as predictors of CPN with 100% and 78% specificity, respectively.</p> Conclusion <p>Among HCC patients who underwent 90Y-TARE with resin microspheres, 73% achieved complete pathologic necrosis. All tumors with a mean tumor absorbed dose ≥ 433&#xa0;Gy achieved CPN.</p> <p>Clinical trial number: not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Histopathologic outcomes of hepatocellular carcinoma treated with transarterial radioembolization with yttrium-90 resin microspheres

  • 期刊论文

  • 发表日期：

    2025年8月5日

查看全文
  • Ammar Sarwar,
  • Imad Nasser,
  • Jeffrey L. Weinstein,
  • Mahmoud Odeh,
  • Hafsa Babar,
  • Diana Dinh,
  • Michael Curry,
  • Andrea Bullock,
  • Devin Eckhoff,
  • Martin Dib,
  • John A. Parker,
  • Muneeb Ahmed

摘要

Purpose

To evaluate the pathologic outcomes of 90Y-TARE of HCC with resin microspheres prescribed using the single-compartment model and to correlate posttreatment dose with outcomes.

Methods

This retrospective single-center study included adult patients with HCC who underwent 90Y-TARE with resin microspheres before liver transplantation or surgery. Histopathologic evaluation of liver tissue was performed. Complete pathologic necrosis (CPN) was defined as 100% tumor necrosis, extensive necrosis as 50–99%, and partial necrosis as < 50%. Posttreatment voxel-based dosimetry was conducted. Additional subgroup analysis was done to compare tumors with complete and incomplete necrosis.

Results

Among 28 patients (median age, 64 years [IQR, 57–69 years]); 86% males,75% BCLC 0-A) with 37 HCC tumors, complete, extensive and partial pathologic necrosis were achieved in 27/37(73%), 8/37(22%) and 2/37(5%) tumors, respectively. Tumors with CPN were significantly smaller than those without CPN (2.2 vs. 3.4 cm, P = 0.03), with longer interval between the 90Y-TARE and liver surgery (274 vs. 143 days, P = 0.048). All tumors with a mean tumor absorbed dose ≥ 433 Gy had CPN. Conversely, all tumors in which 4% or more of the tumor volume received a dose less than 100 Gy had incomplete necrosis. ROC analysis identified D95 ≥ 133 Gy (AUC 0.96 [95%CI: 0.9-1]) and V0-100 (%) < 5% (AUC 0.9 [95%CI: 0.75–0.97]) as predictors of CPN with 100% and 78% specificity, respectively.

Conclusion

Among HCC patients who underwent 90Y-TARE with resin microspheres, 73% achieved complete pathologic necrosis. All tumors with a mean tumor absorbed dose ≥ 433 Gy achieved CPN.

Clinical trial number: not applicable.